Overview

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • SpeciesHuman
    • Amino acids50 to 132

Specifications

Our Abpromise guarantee covers the use of ab90536 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

  • Purity> 95 % SDS-PAGE.

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 5mM Magnesium chloride, 32mM Tris HCl, 200mM Sodium chloride, pH 7.6

General Info

  • Alternative names
    • c Raf
    • C-raf
    • C-Raf proto-oncogene, serine/threonine kinase
    • CMD1NN
    • cRaf
    • Craf 1 transforming gene
    • Craf1 transforming gene
    • EC 2.7.11.1
    • kinase Raf1
    • Murine sarcoma 3611 oncogene 1
    • NS5
    • Oncogene MIL
    • Oncogene RAF1
    • OTTHUMP00000160218
    • OTTHUMP00000207813
    • OTTHUMP00000209389
    • Protein kinase raf 1
    • Proto-oncogene c-RAF
    • RAF
    • Raf 1
    • Raf 1 proto oncogene serine/threonine kinase
    • Raf proto oncogene serine/threonine protein kinase
    • RAF proto-oncogene serine/threonine-protein kinase
    • RAF-1
    • RAF1
    • RAF1_HUMAN
    • Similar to murine leukemia viral (V-raf-1) oncogene homolog 1
    • TRANSFORMING REPLICATION-DEFECTIVE MURINE RETROVIRUS 3611-MSV
    • v raf 1 murine leukemia viral oncogene homolog 1
    • v-raf murine sarcoma viral oncogene homolog 1
    • vraf1 murine leukemia viral oncogene homolog 1
    see all
  • FunctionInvolved in the transduction of mitogenic signals from the cell membrane to the nucleus. Part of the Ras-dependent signaling pathway from receptors to the nucleus. Protects cells from apoptosis mediated by STK3.
  • Tissue specificityIn skeletal muscle, isoform 1 is more abundant than isoform 2.
  • Involvement in diseaseDefects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.
    Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.
  • Sequence similaritiesBelongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
    Contains 1 phorbol-ester/DAG-type zinc finger.
    Contains 1 protein kinase domain.
    Contains 1 RBD (Ras-binding) domain.
  • Post-translational
    modifications
    Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation at Thr-269 increases its kinase activity. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity.
  • Cellular localizationCytoplasm. Cell membrane. Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes.
  • Information by UniProt

References for Recombinant Human Raf1 protein (ab90536)

ab90536 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab90536.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"